Addex Therapeutics reports half-year financials and R&D updates By Investing.com Stocks September 30, 2024 Addex Therapeutics (ticker: ADXN), a biopharmaceutical company, held its Half-Year 2024 Financial Results and Corporate Update Conference Call on [insert…
Addex Therapeutics reports on Q1 2024 with mixed results By Investing.com Stocks June 6, 2024 In their Q1 2024 financial results conference call, Addex Therapeutics (NASDAQ: ADXN) provided updates on their research and development initiatives,…